Generic drugs likely to benefit from possible drug shortage

Pharmaceutical sources said the sales of generic drugs and bioequivalence-proven medicines will be expanded as the dispute between Zuellig Pharma Korea and its associate wholesalers has dragged on.

Korean generic drug manufacturers are expected to boost their sales on hopes that doctors and pharmacists would positively consider substitute drug prescription and/or dispensing if the shortage o...